Clinical Trial: Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422519) titled 'Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression' on Jan. 23.

Brief Summary: The primary aim of this study is to evaluate the efficacy and tolerability of a combined Virtual Reality (VR)-based mindfulness intervention and pharmacological treatment compared with pharmacological treatment alone in reducing depressive symptoms in patients with Treatment-Resistant Depression (TRD).

Secondary questions this study aims to address include:

1. Does the combined intervention lead to changes in inflammatory blood parameters compared with pharmacological treatment alone?

2. Does the add...